secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amneal Pharmaceuticals, Inc. (AMRX)
CIK:        0001723128
Form:       8-K
Filed at:   2025-07-24T23:59:59+00:00
Accession:  0000950103-25-009253
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amneal prices $600M 6.875% senior secured notes due 2032, upsizes term loan to $2.1B
--------------------------------------------------------------------------------

- $600M notes priced at par with 6.875% coupon, due 2032; downsized from $750M due to term loan increase.
- New term B loans upsized to $2.1B from $1.8B, seven-year maturity.
- Proceeds to refinance existing term B loans in full and repay ABL facility.
- Closing expected August 1, 2025, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1723128/000095010325009253/0000950103-25-009253-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1723128/000095010325009253/dp232033_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-25-009253

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer